Physician

Ajay Chaudhuri, MD

According to 2025 Medicare claims, Ajay Chaudhuri, MD (NPI: 1386631851) practices endocrinology in the Buffalo-Cheektowaga, NY market, with the plurality of this provider's patient population coming from Erie, NY. This provider's primary affiliated billing organization is KALEIDA HEALTH (NPI: 1053441907; TIN: 161533232) and primary practice location at 14221-3647. Chaudhuri is affiliated with the Optimum NY Independent Practice Association, LLC (ACO ID: D0294), participating under the REACH model.

Chaudhuri's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 188 traditional Medicare patients, billed 513 HCPCS/CPT codes, and received $27,349 in Medicare payments. The top billing code was 99215 (Established patient office or other outpatient visit with high level of medical decision making, if using time, 40 minutes or more). Part D data shows 4,630 prescription claims across 505 beneficiaries totaling $1,954,098 in drug costs, led by Ozempic (Semaglutide). DME data shows 312 claims. Open Payments data shows 189 records totaling $305,397. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has changed little. Concurrently, Part D prescription costs did not follow a clear longitudinal pattern. For DME billing, reported payments moved from a lower plateau to a higher plateau, from $10,464 to $74,075.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	323	563	$26,014
2016	401	635	$31,302
2017	283	452	$23,278
2018	291	488	$29,160
2019	247	461	$26,661
2020	199	528	$29,241
2021	218	595	$40,023
2022	242	512	$32,345
2023	202	455	$28,005
2024	188	513	$27,349

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	924	10,427	$2,320,617
2016	747	5,947	$1,523,350
2017	541	4,111	$1,322,255
2018	578	4,230	$1,558,119
2019	636	4,635	$2,015,526
2020	540	4,731	$2,135,284
2021	532	4,781	$2,266,461
2022	521	4,513	$2,234,203
2023	522	4,600	$2,279,294
2024	505	4,630	$1,954,098

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	264	770	$18,927
2016	241	695	$21,677
2017	123	424	$14,839
2018	124	424	$13,337
2019	121	473	$34,125
2020	109	472	$42,087
2021	99	503	$49,846
2022	85	458	$55,155
2023	90	437	$56,985
2024	89	312	$70,906

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
99215	Established patient office or other outpatient visit with high level of medical decision making, if using time, 40 minutes or more	23	25	$103
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	135	204	$68
99232	Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes	17	45	$58
95251	Continuous monitoring of blood sugar level in tissue fluid using sensor under skin with interpretation and report	41	75	$26
G2211	Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's	92	109	$13

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Ozempic	Semaglutide	494	18,156	$580,251
Trulicity	Dulaglutide	179	7,776	$258,440
Mounjaro	Tirzepatide	197	5,940	$212,489
Jardiance	Empagliflozin	181	9,390	$179,302
Somavert	Pegvisomant	11	341	$92,285

Top 5 DME services in 2024

By Total Medicare Payment Amount.

HCPCS Code	HCPCS Description	Supplier Rental Indicator	Total Supplier Beneficiaries	Total Supplier Claims	Total Medicare Payment Amount
A4239	Supply allowance for non-adjunctive, non-implanted continuous glucose monitor (cgm), includes all supplies and accessories, 1 month supply = 1 unit of service	N	35	160	$60,180
E0784	External ambulatory infusion pump, insulin	Y	N/R	11	$3,326
A4224	Supplies for maintenance of insulin infusion catheter, per week	N	N/R	14	$2,810
E2103	Non-adjunctive, non-implanted continuous glucose monitor or receiver	N	11	11	$2,231
A4253	Blood glucose test or reagent strips for home blood glucose monitor, per 50 strips	N	26	71	$1,316

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	154	$106,219	Lilly USA, LLC
Research Payments	Reported research-related payment or transfer-of-value amount.	35	$199,178	Eli Lilly and Company
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Ajay Chaudhuri, MD?

Tedicare shows public-source Medicare data for Ajay Chaudhuri, MD (NPI 1386631851), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Ajay Chaudhuri, MD have ACO affiliation data?

Ajay Chaudhuri, MD is shown with ACO affiliation data for Optimum NY Independent Practice Association, LLC (REACH, ACO ID D0294).

What billing organization is linked to Ajay Chaudhuri, MD?

Ajay Chaudhuri, MD is linked to KALEIDA HEALTH (billing NPI 1053441907) in the available physician profile data.

Does Ajay Chaudhuri, MD have Open Payments data?

Ajay Chaudhuri, MD has 189 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.